Similar articles

• CDH1 C-160A polymorphism and gastric cancer risk: evidence needed for clarification.

  Zhang T, Zhao Z, Cao X, Yao Q. Zhang T, et al. DNA Cell Biol. 2012 Mar;31(3):272; author reply 273-4. doi: 10.1089/dna.2011.1480. Epub 2011 Nov 8. DNA Cell Biol. 2012. PMID: 22066580 No abstract available.
• A meta-analysis of CDH1 C-160A genetic polymorphism and gastric cancer risk.

  Cui Y, Xue H, Lin B, Ni P, Fang JY. Cui Y, et al. DNA Cell Biol. 2011 Nov;30(11):937-45. doi: 10.1089/dna.2011.1257. Epub 2011 May 25. DNA Cell Biol. 2011. PMID: 21612411
• Lack of association between the CDH1 polymorphism and gastric cancer susceptibility: a meta-analysis.

  Jiang B, Zhu K, Shao H, Bao C, Ou J, Sun W. Jiang B, et al. Sci Rep. 2015 Jan 20;5:7891. doi: 10.1038/srep07891. Sci Rep. 2015. PMID: 25599647 Free PMC article.
• CDH1 C-160A promoter polymorphism and gastric cancer risk.

  Corso G, Berardi A, Marrelli D, Pedrazzani C, Garosi L, Pinto E, Roviello F. Corso G, et al. Eur J Cancer Prev. 2009 Feb;18(1):46-9. doi: 10.1097/CEJ.0b013e32830c8d70. Eur J Cancer Prev. 2009. PMID: 19077564
• Meta-analysis: tumour invasion-related genetic polymorphisms and gastric cancer susceptibility.

  Gao L, Nieters A, Brenner H. Gao L, et al. Aliment Pharmacol Ther. 2008 Sep 1;28(5):565-73. doi: 10.1111/j.1365-2036.2008.03760.x. Epub 2008 Jun 9. Aliment Pharmacol Ther. 2008. PMID: 18544073 Review.